Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pharmiva financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
KR2.6 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2019 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 248.0K | 2.6M | |||
| Cost of goods sold | 510.0K | 108.0K | 1.3M | 117.0K | 1.3M |
| Gross profit | (509.0K) | (105.0K) | (1.3M) | 131.0K | 1.3M |
| Gross profit margin, % | 52.8% | 50.8% | |||
| Operating expense total | 3.2M | 6.5M | 12.0M | 19.7M | 23.6M |
| Depreciation and amortization | 780.0K | 666.0K | 1.2M | 1.4M | |
| EBITDA | (3.7M) | (6.6M) | (13.3M) | (19.6M) | (22.3M) |
| EBITDA margin, % | -7904.0% | -847.3% | |||
| EBIT | (3.7M) | (7.4M) | (14.0M) | (20.8M) | (23.7M) |
| EBIT margin, % | -8371.8% | -900.6% | |||
| Interest expense | 170.0K | 46.0K | 48.0K | 1.0K | 4.0K |
| Pre tax profit | (3.9M) | (7.4M) | (14.0M) | (20.8M) | (23.7M) |
| Net Income | (3.9M) | (7.4M) | (14.0M) | (20.8M) | (23.7M) |